An estimated 34.5 million people in the United States have type 2 diabetes (T2D),1 the majority of whom are treated with noninsulin medications.2 An estimated 95% of individuals with T2D are treated with basal insulin only, noninsulin medications, and/or lifestyle interventions.3–5. Here, INS is linked to type 2 diabetes mellitus.